Retrospective Cohort Study
Copyright ©The Author(s) 2018.
World J Clin Oncol. Nov 10, 2018; 9(7): 148-161
Published online Nov 10, 2018. doi: 10.5306/wjco.v9.i7.148
Figure 4
Figure 4 Disease-free survival and overall survival curves and histograms between tumor-node-metastasis staging from AJCC-7th and tumor-node-metastasis staging from AJCC-8th. A: Comparison of 5-year disease-free survival (DFS) by sub-stage from AJCC-7th (P < 0.001); B: Comparison of 5-year DFS by sub-stage from AJCC-8th (P < 0.001); C: Comparison of 5-year overall survival (OS) by sub-stage from AJCC-7th (P < 0.001); D: Comparison of 5-year OS by sub-stage for from AJCC-8th (P < 0.001); E: Comparison of 5-year DFS by stage from AJCC-7th (P < 0.001); F: Comparison of 5-year DFS by stage from AJCC-8th (P<0.001); G: Comparison of 5-year OS by stage from AJCC-7th (P < 0.001); H: Comparison of 5-year OS by stage for from AJCC-8th (P < 0.001); A vs B and C vs D: Survival curves of DFS and OS in stage IVB shift right and those in stage IVC shift left; I-L: Comparison of DFS and OS by sub-stage and stage between staging from AJCC-7th and staging from AJCC-8th, all P < 0.01. DFS: Disease-free survival; OS: Overall survival; TNM: Tumor-node-metastasis.